Authors:
Ascioglu, S
Rex, JH
de Pauw, B
Bennett, JE
Bille, J
Crokaert, F
Denning, DW
Donnelly, JP
Edwards, JE
Erjavec, Z
Fiere, D
Lortholary, O
Maertens, J
Meis, JF
Patterson, TF
Ritter, J
Selleslag, D
Shah, PM
Stevens, DA
Walsh, TJ
Citation: S. Ascioglu et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus, CLIN INF D, 34(1), 2002, pp. 7-14
Authors:
Cuneo, A
Bardi, A
Wlodarska, I
Selleslag, D
Roberti, MG
Bigoni, R
Cavazzini, F
De Angeli, C
Tammiso, E
del Senno, L
Cavazzini, P
Hagemeijer, A
Castoldi, G
Citation: A. Cuneo et al., A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zoneB cell lymphoma, LEUKEMIA, 15(8), 2001, pp. 1262-1267
Authors:
Boogaerts, M
Maertens, J
van Hoof, A
de Bock, R
Fillet, G
Peetermans, M
Selleslag, D
Vandercam, B
Vandewoude, K
Zachee, P
De Beule, K
Citation: M. Boogaerts et al., Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients, J ANTIMICRO, 48(1), 2001, pp. 97-103
Authors:
Nollet, F
Billiet, J
Selleslag, D
Criel, A
Citation: F. Nollet et al., Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing, BONE MAR TR, 28(5), 2001, pp. 511-518
Authors:
de Witte, T
Suciu, S
Verhoef, G
Labar, B
Archimbaud, E
Aul, C
Selleslag, D
Ferrant, A
Wijermans, P
Mandelli, F
Amadori, S
Jehn, U
Muus, P
Boogaerts, M
Zittoun, R
Gratwohl, A
Zwierzina, H
Hagemeijer, A
Willemze, R
Citation: T. De Witte et al., Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS, BLOOD, 98(8), 2001, pp. 2326-2331
Authors:
de Witte, T
Suciu, S
Verhoef, G
Labar, B
Archimbaud, E
Aul, C
Selleslag, D
Ferrant, A
Wijermans, P
Mandelli, F
Amadori, S
Jehn, U
Muus, P
Demuynck, H
Dardenne, M
Zittoun, R
Willemze, R
Gratwohl, A
Apperley, J
Citation: T. De Witte et al., Intensive chemotherapy followed by stem cell transplantation for the treatment of myelodysplastic syndromes, HEMAT BLOOD, 40, 2001, pp. 649-654
Authors:
Hale, G
Jacobs, P
Wood, L
Fibbe, WE
Barge, R
Novitzky, N
du Toit, C
Abrahams, L
Thomas, V
Bunjes, D
Duncker, C
Wiesneth, M
Selleslag, D
Hidajat, M
Starobinski, M
Bird, P
Waldmann, H
Citation: G. Hale et al., CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells, BONE MAR TR, 26(1), 2000, pp. 69-76
Authors:
Deschilder, I
Gordts, B
Van Landuyt, H
Renders, F
Selleslag, D
Citation: I. Deschilder et al., Pasteurella dagmatis septicaemia in an immunocompromised patient without ahistory of dog or cat bites, ACT CLIN B, 55(4), 2000, pp. 225-226
Authors:
Ellis, M
Spence, D
de Pauw, B
Meunier, F
Marinus, A
Collette, L
Sylvester, R
Meis, J
Boogaerts, M
Selleslag, D
Kremery, V
von Sinner, W
MacDonald, P
Doyen, C
Vandercam, B
Citation: M. Ellis et al., An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis, CLIN INF D, 27(6), 1998, pp. 1406-1412